{"@context":{"skos":"http://www.w3.org/2004/02/skos/core#","dc":"http://purl.org/dc/terms/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","xsd":"http://www.w3.org/2001/XMLSchema#"},"@id":"https://homosaurus.org/v3/homoit0001007","dc:identifier":"homoit0001007","skos:prefLabel":"Medication","skos:altLabel":"Pharmaceuticals","rdfs:comment":"Non-recreational drugs as used by members of the LGBTQ+ community.","skos:broader":[{"@id":"https://homosaurus.org/v3/homoit0001366","skos:prefLabel":"Therapies"}],"skos:narrower":[{"@id":"https://homosaurus.org/v3/homoit0000399","skos:prefLabel":"Erection pills"},{"@id":"https://homosaurus.org/v3/homoit0000650","skos:prefLabel":"Hormone blockers"},{"@id":"https://homosaurus.org/v3/homoit0001091","skos:prefLabel":"Passive immune therapy"},{"@id":"https://homosaurus.org/v3/homoit0001130","skos:prefLabel":"PrEP"},{"@id":"https://homosaurus.org/v3/homoit0001138","skos:prefLabel":"Puberty blockers"},{"@id":"https://homosaurus.org/v3/homoit0001981","skos:prefLabel":"HAART (Highly Active Antiretroviral Therapy)"}],"skos:related":[{"@id":"https://homosaurus.org/v3/homoit0000317","skos:prefLabel":"Hormone therapy (Gender)"},{"@id":"https://homosaurus.org/v3/homoit0000380","skos:prefLabel":"Substance use in LGBTQ+ communities"}],"skos:exactMatch":{"@id":"http://id.loc.gov/authorities/subjects/sh85039719"},"skos:hasTopConcept":{"@id":"https://homosaurus.org/v3/homoit0001004"},"dc:replaces":[{"@id":"http://homosaurus.org/v2/medication","skos:prefLabel":"Medication"}],"dc:issued":{"@type":"xsd:date","@value":"2019-05-14"},"dc:modified":{"@type":"xsd:date","@value":"2025-03-20"},"@type":"skos:Concept","skos:inScheme":{"@id":"https://homosaurus.org/v3"},"skos:changeNote":"Version 3.7.1","dc:isReplacedBy":[]}